Loading...

Mitsui Chemicals, Inc.

MITUFPNK
Basic Materials
Chemicals - Specialty
$23.28
$0.00(0.00%)

Mitsui Chemicals, Inc. (MITUF) Financial Performance & Income Statement Overview

View comprehensive annual and quarterly summaries for Mitsui Chemicals, Inc. (MITUF), featuring income statements, balance sheets, and cash flow data.

Revenue Growth
3.40%
3.40%
Operating Income Growth
25.38%
25.38%
Net Income Growth
-35.51%
35.51%
Operating Cash Flow Growth
24.27%
24.27%
Operating Margin
5.14%
5.14%
Gross Margin
21.46%
21.46%
Net Profit Margin
1.78%
1.78%
ROE
3.72%
3.72%
ROIC
6.004%
6.004%

Mitsui Chemicals, Inc. (MITUF) Income Statement & Financial Overview

Explore comprehensive income reports for Mitsui Chemicals, Inc. MITUF, broken down by year and quarter.

MetricQ4 2024Q3 2024Q2 2024Q1 2024
Revenue$470.33B$448.49B$440.88B$449.47B
Cost of Revenue$369.87B$351.67B$349.62B$349.71B
Gross Profit$100.46B$96.81B$91.26B$99.76B
Gross Profit Ratio$0.21$0.22$0.21$0.22
R&D Expenses$0.00$0.00$0.00$0.00
SG&A Expenses$77.50B$74.11B$71.01B$72.73B
Operating Expenses$77.50B$74.11B$71.01B$72.73B
Total Costs & Expenses$447.37B$425.78B$420.63B$422.44B
Interest Income$1.22B$2.91B$0.00$6.20B
Interest Expense$6.96B$0.00$4.91B$4.13B
Depreciation & Amortization$25.78B$25.15B$24.49B$24.35B
EBITDA$34.86B$44.77B$39.35B$47.92B
EBITDA Ratio$0.07$0.10$0.09$0.11
Operating Income$22.96B$22.70B$20.25B$27.03B
Operating Income Ratio$0.05$0.05$0.05$0.06
Other Income/Expenses (Net)-$20.85B$1.13B-$8.68B$2.24B
Income Before Tax$2.11B$23.84B$11.56B$25.64B
Income Before Tax Ratio$0.004$0.05$0.03$0.06
Income Tax Expense$9.32B$6.26B$4.46B$8.98B
Net Income-$5.47B$15.48B$4.34B$17.89B
Net Income Ratio-$0.01$0.03$0.010$0.04
EPS-$29.19$82.13$22.82$94.09
Diluted EPS-$29.19$82.13$22.82$94.09
Weighted Avg Shares Outstanding$187.34M$188.50M$190.17M$190.13M
Weighted Avg Shares Outstanding (Diluted)$187.34M$188.50M$190.17M$190.13M

Financial performance has remained strong, with revenue growing from $449.47B in Q1 2024 to $470.33B in Q4 2024. Gross profit continued to perform well, with margins at 21% in the latest quarter. Operating income reached $22.96B in Q4 2024, holding a steady 5% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $34.86B. Net income dropped to -$5.47B, keeping EPS at -$29.19. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.

Unlock 25+ Years of Financial Data

Get access to extended historical data, advanced metrics, and more with our premium plan

Frequently Asked Questions

;